abstract |
The present invention relates to peptides that are N2 sequences of RasGAP protein, fragments thereof, or variants thereof that enhance the ability of drugs to selectively kill cells. Furthermore, the present invention relates to a pharmaceutical composition comprising a pharmaceutically effective amount of the peptide as an active substance. |